I agree that this site is using cookies. You can find further informations here.
X
Karras, Nicole A.
91  results:
Search for persons X
?
1

Phase 1 Trial Investigating the Safety and Tolerability of ..:

Salhotra, Amandeep ; Yang, Dongyun ; Mokhtari, Sally...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S282-S283 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Risk Factors for Hematotoxicity Following Tisagenlecleucel ..:

McNerney, Kevin Owen ; Fabrizio, Vanessa A. ; Talleur, Aimee C....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S219-S220 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Real World Outcomes for AYA Patients with Relapsed/Refracto..:

Lust, Hannah ; Roloff, Gregory ; Schultz, Liora Michal...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S39-S40 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Consolidation with First and Second Allogeneic Transplants ..:

Aldoss, Ibrahim ; Shan, Haoyue ; Yang, Dongyun...
Transplantation and Cellular Therapy.  30 (2024)  8 - p. 788.e1-788.e9 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Yttrium-90 Anti-CD25-BEAM-Conditioning for Autologous Hemat..:

Zain, Jasmine ; Tsai, Ni-Chun ; Palmer, Joycelynne M....
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
6

Cytomegalovirus Triplex vaccine in pediatric hematopoietic ..:

La Rosa, Corinna ; Park, Yoonsuh ; Yang, Dongyun...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
7

Immune Reconstitution Profiling Suggests Antiviral Protecti..:

Szabolcs, Paul ; Mazor, Roei D. ; Yackoubov, Dima...
Transplantation and Cellular Therapy.  29 (2023)  8 - p. 517.e1-517.e12 , 2023
Link: https://doi.org/10.1016/..
 
?
8

High Disease Burden and Severe Neutropenia Predict HLH Toxi..:

McNerney, Kevin O. ; Lim, Stephanie Si ; Miller, Alexandra...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S202-S203 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Mediport use as an acceptable standard for CAR T cell infus..:

Eylon, Maya ; Prabhu, Snehit ; John, Samuel...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
10

Higher doses of tisagenlecleucel are associated with improv..:

Stefanski, Heather E. ; Eaton, Anne ; Baggott, Christina...
Blood Advances.  7 (2023)  4 - p. 541-548 , 2023
Link: https://doi.org/10.1182/..
 
?
11

HLH-like toxicities predict poor survival after the use of ..:

McNerney, Kevin O. ; Si Lim, Stephanie J. ; Ishikawa, Kyle...
Blood Advances.  7 (2023)  12 - p. 2758-2771 , 2023
Link: https://doi.org/10.1182/..
 
?
12

Tisagenlecleucel utilisation and outcomes across refractory..:

Barsan, Valentin ; Li, Yimei ; Prabhu, Snehit...
eClinicalMedicine.  65 (2023)  - p. 102268 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Mediport Use As an Acceptable Standard for CAR T Cell Infus..:

Eylon, Maya ; Baggott, Christina ; Prabhu, Snehit...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S195-S196 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic..:

Lin, Chenyu ; Schwarzbach, Aurelie ; Sanz, Jaime...
Transplantation and Cellular Therapy.  29 (2023)  5 - p. 338.e1-338.e6 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Tisagenlecleucel outcomes in relapsed/refractory extramedul..:

Fabrizio, Vanessa A. ; Phillips, Christine L. ; Lane, Adam...
Blood Advances.  6 (2022)  2 - p. 600-610 , 2022
Link: https://doi.org/10.1182/..
 
1-15